Hepatitis C virus inhibitors
Hepatitis C virus inhibitors having the general formulaare disclosed. Compositions comprising the compounds and methods for using the compounds to inhibit HCV are also disclosed.
Bristol-Myers Squibb Company
A C A A A C C A
A61P C07K A61P A61P A61P C07K C07K A61P
inventional inventional inventional inventional inventional inventional inventional inventional
Barbara Zhizhen Stanley Qian Paul Michael Alan Xiangdong
Zheng D'Andrea Zhao Scola Wang